Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber-Reference-Cited by-同舟云学术

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

Published:2009-09 Issue:3 Volume:124 Page:471-477.e1
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Horak Friedrich,Zieglmayer Petra,Zieglmayer René,Lemell Patrick,Devillier Philippe,Montagut Armelle,Mélac Michel,Galvain Sylvie,Jean-Alphonse Stéphanie,Van Overtvelt Laurence,Moingeon Philippe,Le Gall Martine

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference22 articles.

1. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis;Didier;J Allergy Clin Immunol,2007

2. Efficacy and safety of five grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis;Wahn;J Allergy Clin Immunol,2009

3. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy;Didier;Allergy,2009

4. Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment;Horak;Clin Exp Allergy,2009

5. Exposure to grass pollen in Europe;Jaeger;Clin Exp Allergy Rev,2008

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sublingual versus subcutaneous allergen immunotherapy in bronchial asthma: A randomized controlled trial;The Egyptian Journal of Chest Diseases and Tuberculosis;2024-01

2. Allergen immunotherapy: progress and future outlook;Expert Review of Clinical Immunology;2023-05-05

3. Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States;The Journal of Allergy and Clinical Immunology: In Practice;2023-04

4. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023;International Forum of Allergy & Rhinology;2023-03-06

5. Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling;Molecular Immunology;2023-03